ESMO GI 2026: KRYSTAL-10 misses primary endpoints despite improved response rates in KRAS G12C-mutated metastatic colorectal cancer
The combination of adagrasib and cetuximab did not significantly improve progression-free survival (PFS) or overall…
The combination of adagrasib and cetuximab did not significantly improve progression-free survival (PFS) or overall…
By Prof. Martin Widschwendter, Director, The Daffodil Centre, a partnership between Cancer Council NSW and…
ASCO Special Part 2: Quick Bite Marathon! The Oncology Journal Club Podcast hosted by Professor…
From mouthwatering results in one of the most talked-about pancreatic cancer papers of the year, through to Bob Marley’s melanoma, this episode unpacks the latest oncology papers. With thanks to our Host Craig Underhill, joined by Dr Kate Clarke and Professor Christopher Jackson…
The report “Lancet Oncology Commission on Cancer Workforce: A Global Crisis” was launched at the…
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) David Reardon, MD, director…
From mouthwatering results in one of the most talked-about pancreatic cancer papers of the year, through to Bob Marley’s melanoma, this episode unpacks the latest oncology papers. With thanks to our Host Craig Underhill, joined by Dr Kate Clarke and Professor Christopher Jackson…
Sleep deprivation has long been known to weaken the immune system. Now University of Florida…
Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced clinical…
A new review was published in Volume 17 of Oncotarget, titled Cancer without borders: Policy frameworks for…